Sara H Goodman1, Ashley L Grosso, Sosthenes C Ketende, Gautier H Ouedraogo, Seni Kouanda, Odette Ky-Zerbo, Césaire Samadoulougou, Stefan Baral. 1. From the *Johns Hopkins School of Medicine Center for Child & Community Health Research; † Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology; ‡Key Populations Program Center for Public Health and Human Rights, Baltimore, MD; §Institut de Recherche en Sciences de la Santé (IRSS), Bobo Dioulasso, Burkina Faso; ¶Institut de Recherche en Sciences de la Santé-IRSS Maitre de Recherche Chef de Département Biomédical et Santé Publique, Ouagadougou, Burkina Faso; and ∥Programme d'Appui au Monde Associatif Communautaire de Lutte Contre le VIH/SIDA (PAMAC), Ouagadougou, Burkina Faso.
Abstract
BACKGROUND: Men who have sex with men (MSM) are a population at risk for HIV acquisition and transmission and other sexually transmitted infections (STIs). In Burkina Faso, the prevalence of HIV among MSM is higher than that of other reproductive-aged adults. Early and frequent STI testing and treatment can help prevent HIV acquisition and transmission and may improve linkage to care. METHODS: A cross-sectional study used respondent-driven sampling of MSM in the urban centers of Ouagadougou and Bobo-Dioulasso, Burkina Faso, to complete a questionnaire and HIV and syphilis testing. The binary-dependent variable in these analyses was self-reported prior STI testing in the past 12 months. Independent variables included sociodemographic characteristics, sexual behaviors, and psychosocial factors, selected according to the modified social ecological model. Bivariate associations at the P<0.05 level were used to create a manual forward stepwise multivariable logistic regression. RESULTS: Seventy-six percent of participants (511/672) did not test for STIs in the last 12 months. Testing for STIs was associated with STI symptoms (odds ratio [OR], 2.56; 95% confidence interval [95% CI], 1.39-4.76) and independently associated with depressive symptoms (adjusted OR, 1.49; 95% CI, 1.01-2.20) and discussing HIV and STIs with main male partners (adjusted OR, 1.73; 95% CI, 1.23-1.76). CONCLUSIONS: These data suggest that periodic targeted STI screening for MSM in Burkina Faso may represent an important component of comprehensive HIV prevention programming. The relationship between depression and STI risks is well established, and these data further indicate that screening for depression may be warranted during these clinical encounters.
BACKGROUND:Men who have sex with men (MSM) are a population at risk for HIV acquisition and transmission and other sexually transmitted infections (STIs). In Burkina Faso, the prevalence of HIV among MSM is higher than that of other reproductive-aged adults. Early and frequent STI testing and treatment can help prevent HIV acquisition and transmission and may improve linkage to care. METHODS: A cross-sectional study used respondent-driven sampling of MSM in the urban centers of Ouagadougou and Bobo-Dioulasso, Burkina Faso, to complete a questionnaire and HIV and syphilis testing. The binary-dependent variable in these analyses was self-reported prior STI testing in the past 12 months. Independent variables included sociodemographic characteristics, sexual behaviors, and psychosocial factors, selected according to the modified social ecological model. Bivariate associations at the P<0.05 level were used to create a manual forward stepwise multivariable logistic regression. RESULTS: Seventy-six percent of participants (511/672) did not test for STIs in the last 12 months. Testing for STIs was associated with STI symptoms (odds ratio [OR], 2.56; 95% confidence interval [95% CI], 1.39-4.76) and independently associated with depressive symptoms (adjusted OR, 1.49; 95% CI, 1.01-2.20) and discussing HIV and STIs with main male partners (adjusted OR, 1.73; 95% CI, 1.23-1.76). CONCLUSIONS: These data suggest that periodic targeted STI screening for MSM in Burkina Faso may represent an important component of comprehensive HIV prevention programming. The relationship between depression and STI risks is well established, and these data further indicate that screening for depression may be warranted during these clinical encounters.
Authors: James Stannah; Elizabeth Dale; Jocelyn Elmes; Roisin Staunton; Chris Beyrer; Kate M Mitchell; Marie-Claude Boily Journal: Lancet HIV Date: 2019-10-07 Impact factor: 12.767
Authors: Jura L Augustinavicius; Stefan D Baral; Sarah M Murray; Kevon Jackman; Qian-Li Xue; Travis H Sanchez; Rebecca G Nowak; Trevor A Crowell; Maria Zlotorzynska; Oluwasolape Olawore; Carrie E Lyons; Iliassou M Njindam; Ubald Tamoufe; Daouda Diouf; Fatou Drame; Seni Kouanda; Abo Kouame; Man E Charurat; Simplice Anato; Tampose Mothopeng; Zandile Mnisi; Jeremy C Kane Journal: Am J Epidemiol Date: 2020-07-01 Impact factor: 4.897
Authors: Pamela Y Collins; Jennifer Velloza; Tessa Concepcion; Linda Oseso; Lydia Chwastiak; Christopher G Kemp; Jane Simoni; Bradley H Wagenaar Journal: J Int AIDS Soc Date: 2021-06 Impact factor: 5.396